Title:
併用抗癌療法とその医薬組成物
Document Type and Number:
Japanese Patent JP2008507499
Kind Code:
A
Abstract:
This invention relates to anticancer therapy and more precisely to the immunological control of cancer. Specifically this invention relates to pharmaceutical compositions incorporating as the active ingredient at least one immuno-stimulating agent with charged or central groups of general formula I wherein X, Y, A, B, R1 and R2 are as defined in the specification together with a radiotherapy method suitable to fight cancer or together with a known antineoplastic chemotherapeutic agent selected from the group consisting of alkylating agents, anti-metabolic agents, agents acting on tubules and tyrosine Kinase inhibitors in conjunction or admixture with an inert non toxic pharmaceutically acceptable diluent or carrier. This invention also relates to the salts of a compound of general formula I with a mineral or organic base, namely a pharmaceutically-acceptable base. Use for treating cancer conditions within a single container or disposed within distinct container
More Like This:
Inventors:
Bowel, Jack, Alan
Caravaloli, carlo
Caravaloli, carlo
Application Number:
JP2007522042A
Publication Date:
March 13, 2008
Filing Date:
March 10, 2005
Export Citation:
Assignee:
OM Pharma
International Classes:
A61K45/00; A61K31/282; A61K31/513; A61K31/661; A61K31/675; A61K31/7028; A61K31/7032; A61K31/704; A61K33/243; A61K38/21; A61K45/06; A61K49/00; A61P35/00
Attorney, Agent or Firm:
Takashi Koshiba